MyD88
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
SIGN UP FREE[{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1607349395/vyze8rnjxrxdic6apqcz.svg#/keystone/api/icons/5fce3497746c1c00288b1402/myd88-03.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fce3497746c1c00288b1402/myd88-03.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1607349395/eh55m4lhsenkyshfjuo4.svg#/keystone/api/icons/5fce3497746c1c00288b1401/myd88-03.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fce3497746c1c00288b1401/myd88-03.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1607349395/ypffjveh4pw90nrmgnck.svg#/keystone/api/icons/5fce3497746c1c00288b1400/myd88-03.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fce3497746c1c00288b1400/myd88-03.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1607349395/nfblnqdipu57pcbzevza.svg#/keystone/api/icons/5fce3497746c1c00288b13ff/myd88-03.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fce3497746c1c00288b13ff/myd88-03.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1607349395/vekwbbffqume08r8r2id.svg#/keystone/api/icons/5fce3497746c1c00288b13fe/myd88-03.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fce3497746c1c00288b13fe/myd88-03.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1607349395/jwkyaa3ti5mrebywezjl.svg#/keystone/api/icons/5fce3497746c1c00288b13fd/myd88-03.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fce3497746c1c00288b13fd/myd88-03.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1607349395/qdyyvysagpszphxf8u1z.svg#/keystone/api/icons/5fce3497746c1c00288b13fc/myd88-03.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fce3497746c1c00288b13fc/myd88-03.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1607349395/ughgnnxulaxtnv1uxigx.svg#/keystone/api/icons/5fce3497746c1c00288b13fb/myd88-03.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fce3497746c1c00288b13fb/myd88-03.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1607349395/co3ukizhxjf7h9omhplr.svg#/keystone/api/icons/5fce3497746c1c00288b13fa/myd88-03.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fce3497746c1c00288b13fa/myd88-03.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1607349395/tguoboaivwprsczghy9q.svg#/keystone/api/icons/5fce3497746c1c00288b13f9/myd88-03.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fce3497746c1c00288b13f9/myd88-03.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1607349395/anpcc4jc33054rfkhaty.svg#/keystone/api/icons/5fce3497746c1c00288b13f8/myd88-03.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fce3497746c1c00288b13f8/myd88-03.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1607349395/t2eagmozyvsb1y7jmu1o.svg#/keystone/api/icons/5fce3497746c1c00288b13f7/myd88-03.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fce3497746c1c00288b13f7/myd88-03.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1607349395/rsaixpslchcu9vubbuhr.svg#/keystone/api/icons/5fce3497746c1c00288b13f6/myd88-03.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fce3497746c1c00288b13f6/myd88-03.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1607349395/fwwxzz6ebxt9rpppnfwf.svg#/keystone/api/icons/5fce3497746c1c00288b13f5/myd88-03.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fce3497746c1c00288b13f5/myd88-03.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1607349395/qgfx3rhbpge0nsg0nhvt.svg#/keystone/api/icons/5fce3497746c1c00288b13f4/myd88-03.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fce3497746c1c00288b13f4/myd88-03.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1607349395/sae3bjivttrnttkgizse.svg#/keystone/api/icons/5fce3497746c1c00288b13f3/myd88-03.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fce3497746c1c00288b13f3/myd88-03.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1607349395/rrs7xhwiejtvx10pl4qc.svg#/keystone/api/icons/5fce3497746c1c00288b13f2/myd88-03.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fce3497746c1c00288b13f2/myd88-03.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1607349395/th2gawqxdbc66qqs5sce.svg#/keystone/api/icons/5fce3497746c1c00288b13f1/myd88-03.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fce3497746c1c00288b13f1/myd88-03.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1607349395/rytelxkrvwjwufbpyebs.svg#/keystone/api/icons/5fce3497746c1c00288b13f0/myd88-03.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fce3497746c1c00288b13f0/myd88-03.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1607349395/opnyittkbkjn1o5ezzp1.svg#/keystone/api/icons/5fce3497746c1c00288b13ef/myd88-03.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fce3497746c1c00288b13ef/myd88-03.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1607349395/ya5uthknmgqfsshh3wrj.svg#/keystone/api/icons/5fce3497746c1c00288b13ee/myd88-03.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fce3497746c1c00288b13ee/myd88-03.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1607349395/t90bjcid3vi5tq15t8su.svg#/keystone/api/icons/5fce3497746c1c00288b13ed/myd88-03.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fce3497746c1c00288b13ed/myd88-03.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1607349395/qdhhse5lhzjqa7wqfjbd.svg#/keystone/api/icons/5fce3497746c1c00288b13ec/myd88-03.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fce3497746c1c00288b13ec/myd88-03.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1607349395/rwtuhdsnfvte4sqe3xym.svg#/keystone/api/icons/5fce3497746c1c00288b13eb/myd88-03.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fce3497746c1c00288b13eb/myd88-03.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1607349395/mefkbt9nt77fk7srmrgx.svg#/keystone/api/icons/5fce3497746c1c00288b13ea/myd88-03.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fce3497746c1c00288b13ea/myd88-03.png"}]
Keywords
MYD88,myeloid differentiation primary response 88,MYD88D,IRAK1,IRAK2,interleukin 1 receptor,RAC1,TLR4,TLR,myd88,myd88d,irak1,irak2